ONCY ONCOLYTICS BIOTECH INC
Price Chart
Executive Summary
Oncolytics Biotech filed a shelf registration (S-3) to offer up to $250 million in securities, including common stock, preferred stock, warrants, purchase contracts, and units. This filing replaces a prior registration and carries forward $139 million in unsold securities. The shelf allows the company to raise capital opportunistically over time, signaling potential future dilution.
Key Financial Metrics
Actionable Insight
Monitor for future prospectus supplements that will disclose specific offering terms. The large size relative to market cap suggests this could be a significant dilutive event. Given the company's clinical-stage status and lack of revenue, this capital raise is likely necessary for operations, but represents substantial shareholder dilution risk.
Key Facts
- Filed S-3 shelf registration for up to $250 million in securities
- Includes common stock, preferred stock, warrants, purchase contracts, and units
- Carries forward $139 million in unsold securities from a prior registration
- Market cap is $91 million, meaning the offering could result in over 170% dilution if fully utilized
- Recent insider activity shows minimal buying ($15K total)
- Company recently redomesticated to Nevada from Canada
Financial Impact
Up to $250 million in potential dilution, representing 173% of current market cap
Risk Factors
- Significant dilution to existing shareholders if the full $250 million is issued
- Potential for opportunistic timing at low stock prices
- No guaranteed use of proceeds specified, increasing uncertainty
- Clinical-stage biotech with no revenue, increasing investment risk
Market Snapshot
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001104659-26-038078 |
| Document: tm2610569d1_ex3-3.htm | 0001104659-26-038078 |
| Document: tm2610569d1_exfilingfees.htm | 0001104659-26-038078 |
| Document: tm2610569d1_ex5-1.htm | 0001104659-26-038078 |
| Document: tm2610569d1_ex3-2.htm | 0001104659-26-038078 |
| Document: tm2610569d1_ex5-2.htm | 0001104659-26-038078 |
| Document: tm2610569d1_ex23-1.htm | 0001104659-26-038078 |
| Document: 0001104659-26-038078-index-headers.html | 0001104659-26-038078 |
| Document: 0001104659-26-038078-index.html | 0001104659-26-038078 |
| Document: 0001104659-26-038078.txt | 0001104659-26-038078 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
10d ago
|
8-K
| $0.9300 $0.8800 | ▼ −5.38% | ▼ −4.68% | $0.8000 (−13.98%) |
|
Jun 1, 2026
11d ago
|
8-K
| $1.06 $0.9300 | ▼ −12.26% | ▼ −12.41% | $0.8000 (−24.53%) |
|
May 22, 2026
21d ago
|
8-K
| $0.8100 $0.8100 | · 0.00% | ▼ −0.59% | $0.8000 (−1.23%) |
|
May 22, 2026
21d ago
|
Press Release
| $0.8100 $0.8100 | · 0.00% | ▼ −0.59% | $0.8000 (−1.23%) |
|
Apr 27, 2026
6w ago
|
8-K
| $0.9700 $0.9000 | ▼ −7.22% | ▼ −6.73% | $0.8000 (−17.53%) |
|
Apr 6, 2026
9w ago
|
424B5
| $0.9000 $0.9100 | ▼ −1.11% | ▲ +1.43% | $0.8000 (+11.11%) |
|
Apr 6, 2026
9w ago
|
8-K
| $0.9500 $0.9000 | ▼ −5.26% | ▼ −5.33% | $0.8000 (−15.79%) |
|
Apr 6, 2026
9w ago
|
EFFECT
| $0.9500 $0.9000 | ▲ +5.26% | ▲ +5.33% | $0.8000 (+15.79%) |
|
Apr 1, 2026
10w ago
|
S-3
| $0.9300 $0.9600 | ▼ −3.23% | ▼ −3.15% | $0.8000 (+13.98%) |
|
Mar 11, 2026
13w ago
|
Insider Cluster
| $1.01 $0.9600 | ▼ −4.95% | ▼ −3.47% | $0.8000 (−20.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access